Axogen (AXGN) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 787.00 |
| Dec 31, 2025 | 924.00 |
| Mar 31, 2025 | 2,259.00 |
| Dec 31, 2024 | 2,155.00 |
| Sep 30, 2024 | 1,645.00 |
| Jun 30, 2024 | 1,264.00 |
| Mar 31, 2024 | 680.00 |
| Dec 31, 2023 | 88.00 |
| Sep 30, 2023 | -331.00 |
| Jun 30, 2023 | -145.00 |
| Mar 31, 2023 | 847.00 |
| Dec 31, 2022 | 429.00 |
| Sep 30, 2022 | 1,117.00 |
| Jun 30, 2022 | 862.00 |
| Mar 31, 2022 | 857.00 |
| Dec 31, 2021 | 1,582.00 |
| Sep 30, 2021 | 1,662.00 |
| Jun 30, 2021 | 1,980.00 |
| Mar 31, 2021 | 1,803.00 |
| Dec 31, 2020 | 1,314.00 |
| Mar 31, 2020 | 2,686.00 |
| Dec 31, 2019 | 3,850.00 |
| Sep 30, 2019 | 2,994.00 |
| Jun 30, 2019 | 2,874.00 |
| Mar 31, 2019 | 2,452.00 |
| Dec 31, 2018 | 2,216.00 |
| Sep 30, 2018 | 3,114.00 |
| Jun 30, 2018 | 4,456.00 |
| Mar 31, 2018 | 2,294.00 |
| Dec 31, 2017 | 3,628.00 |
| Sep 30, 2017 | 9,739.00 |
| Jun 30, 2017 | 8,884.00 |
| Mar 31, 2017 | 6,286.00 |
| Dec 31, 2016 | 3,129.00 |
| Sep 30, 2016 | 2,497.00 |